NONE

Company

Forte Biosciences, Inc.

Filed

May 24, 2022

Accession Number

0001567619-22-011599

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →